Table: Chordia Therapeutics - Q1 parent results

Chordia Therapeutics

14/01/2026 06:32

Jan 14 (Reuters)- 
             Chordia Therapeutics Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Nov 30, 2025        Nov 30, 2024      Aug 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Operating     loss 306 mln        loss 624 mln        loss 2.01   
  Recurring     loss 294 mln        loss 615 mln        loss 1.96   
  Net           loss 295 mln        loss 616 mln        loss 1.96   
  EPS           loss 4.24 yen       loss 9.07 yen    loss 28.41 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Chordia Therapeutics Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T